HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis.

Abstract
We investigated the efficacy of the peptide s-thanatin alone and in combination with tigecycline in an animal model of sepsis induced by cecal ligation and puncture. Adult male Wistar rats were randomized to receive intravenously isotonic sodium chloride solution, 5mg/kg s-thanatin, 2mg/kg tigecycline, 5mg/kg s-thanatin combined with 2mg/kg tigecycline. The experiment was also performed with administration of the drugs 360 min after the surgical procedure to better investigate the clinical situation where there is an interval between the onset of sepsis and the initiation of therapy. Lethality, bacterial growth in blood, peritoneum, spleen and liver, and NO indices were evaluated. All compounds reduced the lethality when compared to control. In all experiments, the compounds reduced significantly bacterial growth and lethality compared with saline treatment. Treatment with s-thanatin resulted in significant decrease in plasma NO levels compared to tigecycline and control group. The combination between s-thanatin and tigecycline proved to be the most effective treatment in reducing all variables measured. S-thanatin may have potential therapeutic usefulness alone and when associated to tigecycline in polymicrobial peritonitis.
AuthorsOscar Cirioni, Guoqiu Wu, Linxian Li, Fiorenza Orlando, Carmela Silvestri, Roberto Ghiselli, Zilong Shen, Alessandro Scalise, Eleonora Gabrielli, Daniele Scuppa, Chiara Romiti, Mauro Provinciali, Mario Guerrieri, Andrea Giacometti
JournalPeptides (Peptides) Vol. 31 Issue 7 Pg. 1231-6 (Jul 2010) ISSN: 1873-5169 [Electronic] United States
PMID20381561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • thanatin
  • Tigecycline
  • Minocycline
Topics
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Antimicrobial Cationic Peptides (therapeutic use)
  • Disease Models, Animal
  • Male
  • Minocycline (analogs & derivatives, metabolism, therapeutic use)
  • Models, Animal
  • Peritonitis (drug therapy, microbiology)
  • Rats
  • Rats, Wistar
  • Tigecycline
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: